OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells presents a paramount challenge for the biopharmaceutical industry. A variety of strategies can be employed enhance antibody titer, such as process parameter optimization, media optimization, and implementation of perfusion technologies. Fine-tuning growth p